Global Access Program

The Global Access Program (GAP) is an initiative designed to provide affordable access to essential medicines and healthcare products in developing countries. It typically involves collaborations between pharmaceutical companies, governments, and non-profit organizations to ensure that people in need can obtain vital treatments at lower costs. The program aims to improve health outcomes by addressing barriers such as high prices and limited availability, often through licensing agreements, donation efforts, or manufacturing partnerships. Overall, GAP promotes equitable healthcare access globally, especially for underserved populations, while supporting sustainable solutions for medical needs.